semaglutide gastroparesis law firm in kentucky Ozempic Lawsuit Lawyer Liraglutide Claim Eligibility for Injured
Description
Retatrutide is an investigational drug and not approved by the FDA for any indication as of May 2026
Tirzepatide mimics the action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
This residual activity may sustain local IL-17/IL-23 signalling and prime flares
Indications: Type 2 diabetes mellitus : Helps lower blood sugar levels
Strategic Implication: By attacking the integrity of the product rather than just the rights to the molecule, Lilly frames the issue as one of public safety, which resonates more strongly with judges and the public than a pure IP dispute
